A Day Up For Translate Bio, Inc.

Fri, Feb 23, 2024 at 07:06 PM
A Day Up For Translate Bio, Inc.

Translate Bio, Inc. (TBIO:NASDAQ) shot up at $0.78, representing a gain of 72.3%. On Fri, Feb 23, 2024, TBIO:NASDAQ hit a New 2-Week High of $0.78. From Fri, Feb 09, 2024, the stock recorded 55.56% Up Days and 40.00% Green Days

About Translate Bio, Inc. (TBIO:NASDAQ)

Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.